Carbohydrate-deficient glycoprotein syndrome type Ib. Phosphomannose isomerase deficiency and mannose therapy.
نویسندگان
چکیده
Phosphomannose isomerase (PMI) deficiency is the cause of a new type of carbohydrate-deficient glycoprotein syndrome (CDGS). The disorder is caused by mutations in the PMI1 gene. The clinical phenotype is characterized by protein-losing enteropathy, while neurological manifestations prevailing in other types of CDGS are absent. Using standard diagnostic procedures, the disorder is indistinguishable from CDGS type Ia (phosphomannomutase deficiency). Daily oral mannose administration is a successful therapy for this new type of CDG syndrome classified as CDGS type Ib.
منابع مشابه
Can glycohemoglobin be used to assess glycemic control in patients with chronic renal failure?
false-positive results in S. pneumoniae cases because only the amount of CDT (a-to di-or trisialotransferrin) and/or the CDT/transferrin ratio is determined (19). HUS associated with S. pneumoniae therefore has to be considered in the diagnosis of primary and secondary defects in the glycan part of N-glycoproteins. The non-S. pneumoniae-associated HUS cases showed normal isoform distribution in...
متن کاملLETTER TO JMG Protein losing enteropathy-hepatic fibrosis syndrome in Saguenay-Lac St-Jean, Quebec is a congenital disorder of glycosylation type Ib
Congenital disorders of glycosylation (CDG) are newly described inborn errors of metabolism involving glycan moiety synthesis. CDG Ib is caused by a deficiency of cellular phosphomannose isomerase (EC 5.4.2.28) resulting from the presence of mutations in the corresponding gene, MPI, 6 on chromosome 15 (mutation database: http:// www.med.kuleuven.ac.be/cdg/). CDG Ib differs clinically from the o...
متن کاملProtein losing enteropathy-hepatic fibrosis syndrome in Saguenay-Lac St-Jean, Quebec is a congenital disorder of glycosylation type Ib.
Congenital disorders of glycosylation (CDG) are newly described inborn errors of metabolism involving glycan moiety synthesis. CDG Ib is caused by a deficiency of cellular phosphomannose isomerase (EC 5.4.2.28) resulting from the presence of mutations in the corresponding gene, MPI, 6 on chromosome 15 (mutation database: http:// www.med.kuleuven.ac.be/cdg/). CDG Ib differs clinically from the o...
متن کاملGenetic and biochemical studies on mannose-negative mutants that are deficient in phosphomannose isomerase in Escherichia coli K-12.
Two mannose-negative mutants of Escherichia coli K-12 have been isolated. These mutants are deficient in the ability to synthesize phosphomannose isomerase and capsular polysaccharide when grown on glucose-containing media. Interrupted mating experiments to determine the kinetics of genetic transfer show that the two mannose-negative mutations map together between the histidine and tryptophan r...
متن کاملThe de novo and salvage pathways of GDP-mannose biosynthesis are both sufficient for the growth of bloodstream-form Trypanosoma brucei
The sugar nucleotide GDP-mannose is essential for Trypanosoma brucei. Phosphomannose isomerase occupies a key position on the de novo pathway to GDP-mannose from glucose, just before intersection with the salvage pathway from free mannose. We identified the parasite phosphomannose isomerase gene, confirmed that it encodes phosphomannose isomerase activity and localized the endogenous enzyme to ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- The Journal of clinical investigation
دوره 101 7 شماره
صفحات -
تاریخ انتشار 1998